| 1. |
Liu Y, Wang Y, Zhao K, et al. Lymph node metastasis in young and middle-aged papillary thyroid carcinoma patients: a SEER-based cohort study. BMC Cancer, 2020, 20(1): 181. doi: 10.1186/s12885-020-6675-0.
|
| 2. |
Zhou SL, Guo YP, Zhang L, et al. Predicting factors of central lymph node metastasis and BRAFV600E mutation in Chinese population with papillary thyroid carcinoma. World J Surg Oncol, 2021, 19(1): 211. doi: 10.1186/s12957-021-02326-y.
|
| 3. |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid, 2016, 26(1): 1-133.
|
| 4. |
中國臨床腫瘤學會指南工作委員會. 中國臨床腫瘤學會(CSCO)分化型甲狀腺癌診療指南2021. 腫瘤預防與治療, 2021, 34(12): 1164-1200.
|
| 5. |
Lallemant B, Reynaud C, Alovisetti C, et al. Updated definition of level Ⅵ lymph node classification in the neck. Acta Otolaryngol, 2007, 127(3): 318-322.
|
| 6. |
Zhou T, Wu F, Zhao L, et al. A meta-analysis of risk factors for lymph node posterior to the right recurrent laryngeal nerve metastasis in papillary thyroid carcinoma. Gland Surg, 2021, 10(6): 1841-1851.
|
| 7. |
張浩, 孫威. 頸淋巴結清掃術易遺漏轉移淋巴結部位及其對策. 中國實用外科雜志, 2017, 37(9): 965-970.
|
| 8. |
中華人民共和國國家衛生健康委員會. 甲狀腺癌診療規范(2018年版). 中華普通外科學文獻(電子版), 2019, 13(1): 1-15.
|
| 9. |
孫一心, 王朝暉, 陳錦, 等. 甲狀腺乳頭狀癌右側喉返神經深方淋巴結轉移危險因素分析. 中國實用外科雜志, 2023, 43(6): 708-713.
|
| 10. |
Wang Z, Chang Q, Zhang H, et al. A clinical predictive model of central lymph node metastases in papillary thyroid carcinoma. Front Endocrinol (Lausanne), 2022, 13: 856278. doi: 10.3389/fendo.2022.856278.
|
| 11. |
Diessl S, Holzberger B, M?der U, et al. Impact of moderate vs stringent TSH suppression on survival in advanced differentiated thyroid carcinoma. Clin Endocrinol (Oxf), 2012, 76(4): 586-592.
|
| 12. |
王慧芳, 于博, 趙文君, 等. cN0甲狀腺微小乳頭狀癌右側喉返神經后方淋巴結轉移及清掃研究進展. 中國普通外科雜志, 2020, 29(5): 603-610.
|
| 13. |
Li J, He G, Tong Y, et al. A novel scoring system for the risk of papillary thyroid cancer metastases in lymph nodes posterior to the right of the recurrent laryngeal nerve. Endocr Pract, 2021, 27(1): 15-20.
|
| 14. |
Kim D, Kwon HK, Shin SC, et al. Right posterior paratracheal lymph nodes metastasis is one of the predictive factors in right-sided papillary thyroid carcinoma. Surgery, 2019, 166(6): 1154-1159.
|
| 15. |
朱一鳴, 劉紹嚴. 甲狀腺癌術后復發再手術難點與對策. 中國實用外科雜志, 2021, 41(8): 856-860.
|
| 16. |
關淯夫. cN0期甲狀腺乳頭狀癌右側喉返神經背側淋巴結轉移相關危險因素分析. 大連: 大連醫科大學, 2020.
|
| 17. |
Chen F, Jin Y, Feng L, et al. RRS1 gene expression involved in the progression of papillary thyroid carcinoma. Cancer Cell Int, 2018, 18: 20. doi: 10.1186/s12935-018-0519-x.
|
| 18. |
Luo Y, Xu XC, Shen J, et al. Model of lymph node metastasis posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma. Cancer Manag Res, 2018, 10: 2449-2455.
|
| 19. |
萬福強, 安玉勝, 任忠峰, 等. 右喉返神經后方淋巴結清掃在cN0期甲狀腺乳頭狀微小癌手術中的探討. 中國綜合臨床, 2017, 33(11): 981-984.
|
| 20. |
彭冬梅, 晏晨, 蘇安平, 等. cN0甲狀腺微小乳頭狀癌右側喉返神經淺面及深面淋巴結轉移危險因素分析. 中國實用外科雜志, 2016, 36(5): 547-551.
|
| 21. |
劉文, 程若川, 蘇艷軍, 等. 甲狀腺微小乳頭狀癌rⅥb區轉移預測因素及rⅥa區、rⅥb區轉移相關性研究. 中國實用外科雜志, 2017, 37(9): 1007-1012.
|
| 22. |
Hou J, Shan H, Zhang Y, et al. Risk factors of metastasis to the lymph nodes posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma. Eur Arch Otorhinolaryngol, 2020, 277(3): 881-886.
|
| 23. |
陳宏存, 李良, 江鳴, 等. 甲狀腺乳頭狀癌右側喉返神經后方淋巴結轉移的相關因素分析及其臨床意義. 國際腫瘤學雜志, 2018, 45(7): 391-394.
|
| 24. |
程鳴鳴, 柴芳, 張曉明. 甲狀腺乳頭狀癌右側喉返神經深層(Ⅵb區)淋巴結轉移的風險分析. 中國現代醫學雜志, 2022, 32(1): 85-90.
|
| 25. |
Zhang DG, Gao L, Miao YW, et al. Risk factors for posterior to right recurrent laryngeal nerve lymph node metastasis in papillary thyroid carcinoma. Saudi Med J, 2014, 35(8): 832-837.
|
| 26. |
孫振華, 趙志泓, 蔣華平. 甲狀腺微小乳頭狀癌rⅥb區淋巴結轉移因素分析及術中納米碳應用價值研究. 臨床耳鼻咽喉頭頸外科雜志, 2020, 34(4): 355-359.
|